Search Results
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
August, 2024
August 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Jul
Vivek
Aug 30, 2023, 17:46 |
Insight
Vivek Subbiah: Adding chemotherapy to cemiplimab at progression might provide a new second-line treatment for patients with advanced non-small-cell lung cancer.
In a post by Vivek Subbiah, the Chief Early-Phase Drug Development at Sarah Cannon Research…
Aug 28, 2023, 17:40 |
Insight
Vivek Subbiah: Lurbinectedin was approved for Small cell Lung in USA and now is also approved in Canada, Australia, Singapore, the United Arab Emirates, Qatar, South Korea, Ecuador, Mexico, Israel and Switzerland.
Aug 27, 2023, 18:58 |
Insight
Vivek Subbiah: The 3rd KRAS G12C kid on the block.
According to Vivek Subbiah, Chief of Early-Phase Drug Development at the Sarah Cannon Research Institute:…
Aug 25, 2023, 16:32 |
Insight
Vivek Subbiah: Huge win for patients with RET+ thyroid cancers.
Quoting Vivek Subbiah, the Chief of Early-Phase Drug Development at the Sarah Cannon Research Institute,…
Aug 20, 2023, 17:41 |
Insight
Vivek Subbiah: Pan-KRAS inhibitors have broad therapeutic implications and merit clinical investigation in patients with KRAS-driven cancers.
According to Vivek Subbiah, Chief, Early-Phase Drug Development, Sarah Cannon Research Institute on LinkedIn: "Pan-KRAS…
Aug 11, 2023, 19:30 |
Drugs
Vivek Subbiah: Pralsetinib has received FULL FDA approval
Exciting News for RET+ patients! Pralsetinib has received FULL FDA approval! From treating the 1st…
Aug 11, 2023, 17:44 |
Insight
Vivek Subbiah: Pleased to share our back-to-back papers unveiling promising results of Lurbinectedin
Hot off the press Pleased to share our back-to-back papers unveiling promising results of Lurbinectedin.…
Aug 1, 2023, 06:57 |
Drugs
🚨It's monday & we have another FDA approval - Vivek Subbiah
🚨It's monday & we have another FDA approval 👉FDA approves dostarlimab-gxly with chemotherapy for endometrial cancer…
Jul 31, 2023, 17:58 |
Blog
Can only movies come in sequels? Academic Papers can too! - Vivek Subbiah
Can only movies come in sequels? Academic Papers can too! Â Excited to introduce the…
Jul 31, 2023, 17:24 |
Drugs
Delighted to share our latest paper on "Tumor-agnostic drug development in dMMR/MSI-H solid tumors" just published in Trends in Cancer - Vivek Subbiah
Hot off the press! Weekend Reading. Â :arrow: Delighted to share our latest paper on "Tumor-agnostic…
21
22
23
24
25
All:
301
Posts:
221 - 230
Highlights on the U.S. - India Cancer Moonshot Dialogue
The Nobel Prize: "Without him my kids wouldn’t be here" - cancer survivor Sharon Belvin
The plight of cancer patients in war-torn regions highlight the urgent need for our collective support - UICC
Top 100 Xfluencers in Sarcoma: Key Opinion Leaders to follow on X (Twitter) in 2024
A Manifesto to Improve Cancer Care in Conflict-Affected Areas: The Lancet
Facebook
RSS Feed
Twitter
Linkedin
Youtube